Endo-Epicardial Versus Only-Endocardial Ablation as a First Line Strategy for the Treatment of Ventricular Tachycardia in Patients with Ischemic Heart Disease

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 4, 2015, Pages 882-889

  Izquierdo, Maite ^a   Sánchez Gómez, Juan Miguel ^a   Ferrero De Loma Osorio, Angel ^a   Martínez, Angel ^a   Bellver, Alejandro ^b   Peláez, Antonio ^c   Núñez, Julio ^a   Núñez, Carlos ^a   Chorro, Javier ^a   Ruiz Granell, Ricardo ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

ablation; chronic ischemic heart disease; electrophysiology

Indexed keywords

ABLATION CATHETER; ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EMERGENCY CARE; ENDOCARDIAL ABLATION; ENDOCARDIAL EPICARDIAL ABLATION; FEMALE; FOLLOW UP; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; SCAR FORMATION; SURGICAL APPROACH; SURVIVAL RATE; TIME TO TREATMENT; VASCULAR ACCESS; COMPLICATION; ELECTROCARDIOGRAPHY; ENDOCARDIUM; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE ISCHEMIA; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; RETROSPECTIVE STUDY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

AGED; CATHETER ABLATION; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84939825216     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.115.002827     Document Type: Article

References (24)

1. Cano O, Hutchinson M, Lin D, Garcia F, Zado E, Bala R, Riley M, Cooper J, Dixit S, Gerstenfeld E, Callans D, Marchlinski F. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol. 2009; 54: 799-808. doi: 10. 1016/j. jacc. 2009. 05. 032.
2. Garcia F, Bazan V, Zado E, Ren J, Marchlinski F. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/displasia. Circulation. 2009; 120: 366-375. doi: 10. 1161/CIRCULATIONAHA. 108. 834903.
3. Bai R, Biase L, Shivkumar K, Mohanty P, tung R, Santangeli P, Saenz L, Vacca M, Verma A, Khaykin Y, Mohanty S, Bukhardt D, Hongo R, Beheiry S, Russo A, Casella M, Pelargonio G, Santarelli P, Sanchez J, tondo C, Natale A. Ablation of ventricular arrhythmias in arrhythmogenic ritht ventricular dysplasia/cardiomyopathy: Arrhythmia-free survival after endo-epicardial substrate based mapping and ablation. Circ Arrhythm Electrophysiol. 2011; 4: 478-485. doi: 10. 1161/CIRCEP. 111. 963066.
4. Berruezo A, Fernandez-Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, Boussy T, Tolosana J, Arbelo E, Brugada J. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. Circ Arrhythm Electrophysiol. 2012; 5: 111-121. doi: 10. 1161/CIRCEP. 110. 960740.
5. Tung R, Michowitz Y, Yu R, Mathuria N, Vaseghi M, Buch E, Bradfield J, Fujimura O, Gima J, Discepolo W, Mandapati R, Boyle N, Shivkumar K. Epicardial ablation of ventricular tachycardia: An institutional experience of safety and efficacy. Heart Rhythm. 2013; 10: 490-498. doi: 10. 1016/j. hrthm. 2012. 12. 013.
6. Schimdt B, Chun KR, Baensch D, Antz M, Koektuerk B, Tilz R, Metzner A, Ouyang F, Kuck K. Catheter ablation for ventricular tachycardia after failed endocardial ablation: epicardial substrate or inappropriate endocardial ablation? Heart Rhythm. 2010; 7: 1746-1752. doi: 10. 1016/j. hrthm. 2010. 08. 010.
7. Della Bella P, Brugada J, Zeppenfeld K, Merino J, Neuzil P, Maury P, Maccabelli G, Vergara P, Baratto F, Berruezo A, Wijnmaalen A. Epicardial ablation for ventricular tachycardia. A European Multicenter Study. Circ Arrhythm Electrophysiol. 2011; 4: 653-659. doi: 10. 1161/ CIRCEP. 111. 962217.
8. Yoshiga Y, Maathew S, Wissner E, Tilz R, Fuernakranz A, Metzner A, Rilling A, Konstantinidou M, Igarashi M, Kuck KH, Ouyang F. Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction. Heart Rhythm. 2012; 9: 1192-1199. doi: 10. 1016/j. hrthm. 2012. 03. 058.
9. Sosa E, Scanavacca M, DÁvila A, Oliveira F, Ramires JA. Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol. 2000; 35: 1442-1449.
10. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94: 495-509. doi: 10. 2307/2670170.
11. Biase L, Santangeli P, Burkhardt DJ, Bai R, Mohanty P, Cardbucichio C, Dello Russo A, Casella M, Mohanty S, Pump A, Hongo R, Beheiry S, Pelargonio G, Santarelli P, Zucchetti M, Horton R, Sanchez JE, Elayi CS, Lakkireddy D, Tondo C, Natale A. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012; 60: 132-141. doi: 10. 1016/j. jacc. 2012. 03. 044.
12. Kaltenbrunner W, Cardinal R, Dubuc M, Shenasa M, Nadeau R, Tremblay G, Vermeulen M, Savard P, Page PL. Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation. 1991; 84: 1058-1071.
13. Littmann L, Svenson RH, Gallagher JJ, Selle JG, Zimmem SH, Fedor JM, Colavita PG. Functional role of the epicardium in postinfarction ventricular tachycardia. Observations derived from computerized epicardial activation mapping, entrainment, and epicardial laser photoablation. Circulation. 1991; 83: 1577-1591.
14. Josephson ME, SimsonMB, Harken AH, Horowith LN, Falcone RA. The incidence and clinical significance of epicardial late potentials in patients with recurrent sustained ventricular tachycardia and coronary artery disease. Circulation. 1982; 66: 1199-1204.
15. Martinek M, Stevenson W, Inada K, Michifumi T, Tedrow U. QRS characteristics fail to reliably identify ventricular tachycardias that require epicardial ablation in ischemic heart disease. J Cardiovasc Electrophysiol. 2012; 23: 188-193. doi: 10. 1111/j. 1540-8167. 2011. 02179. x.
16. Jaïs P, Maury P, Khairy P, Sacher F, Nault I, Komatsu Y, Hocini M, Forclaz A, Jadidi A, Weerasooryia R, Shah A, Derval N, Cochet H, Knecht S, Miyazaki S, Linton N, Rivard L, Wright M, Wilton S, Scherr D, Pascale P, Roten L, Pederson M, Bordachar P, Laurent F, Kim SJ, Ritter P, Climenty J, Haïsaguerre M. Elimination of local abnormal ventricular activities: A new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012; 125: 2184-2196.
17. Bogun F. Ablation for ventricular tachycardia. J Am Coll Cardiol. 2012; 2: 142-143.
18. Tung R, Josephson ME, Reddy V, Reynolds MR. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: An analysis from the substrate mapping and ablation in sinus rhythm to Halt Ventricular Tachycardia Trial (SMASH VT). J Cardiovasc Electrophysiol. 2010; 21: 799-803. doi: 10. 1111/j. 1540-8167. 2009. 01705. x.
19. Carbuccio C, santamaria M, Trevisi N. Catéter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: shortand long-term outcomes in a prospective single-center study. Circulation. 2008; 117: 462-469. doi: 10. 1161/CIRCULATIONAHA. 106. 686534.
20. Izquierdo M, Ruiz-Granell R, Ferrero A, Martínez A, Sánchez-Gomez JM, Bonanad C, Mascarell B, Morell S, García-Civera R. Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome. Europace. 2012; 14: 1734-1739. doi: 10. 1093/europace/eus186.
21. Mallidi J, Nadkarni GN, Berger RD, Calkins H, Nazarian S. Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. Heart Rhythm. 2011; 8: 503-510. doi: 10. 1016/j. hrthm. 2010. 12. 015.
22. Izquierdo M, RuizGranell R, Ferrero A, Martínez A, Dominguez E, Madrazo I, Cuenca I, Garcia Civera R. Valor pronóstico de la taquicardia ventricular lenta en portadores de DAI por prevención secundaria. Rev Esp Cardiol. 2011; 64(suppl 3): 283.
23. Worck R, Haarbo J, Thomsen PE. Electrophysiological study and slow ventricular tachycardia predict appropriate therapy: results from a single-centre implantable cardiac defibrillator follow-up. Europace. 2007; 9: 1048-1053.
24. Al Mohani G, Israel C, Casella M, Carbucchio C. Epicardial ablation as a bailout in electrical storm? Herzschrittmacherther Elektrophysiol. 2014; 25: 93-101. doi: 10. 1007/s00399-014-0308-8.